Science and Technology

Pioneering Discovery: BD Launches Advanced FACSDiscover™ S8 Cell Sorters

FRANKLIN LAKES, N.J., April 5, 2024 /PRNewswire/ - BD (Becton, Dickinson and Company), a global pioneer in medical technology, has announced the international commercial launch of the BD FACSDiscover™ S8 Cell Sorters. This new range promises to empower a more diverse group of scientists conducting cutting-edge research in numerous scientific fields such as cellular biology, cancer studies, and immunology. The state-of-the-art cell sorters aim to unveil critical insights into complex cellular dynamics, advancing our understanding of biological processes in unprecedented ways.

A New Horizon in Cellular Analysis

Utilizing the innovative FACSDiscover™ S8 Cell Sorters, scientists are now capable of validating intricate biological and spatial data in real-time. These advanced devices allow for the acquisition of individual cell imagery and the isolation of cells based on explicit visual markers at unparalleled speeds. This leap forward is complemented by a streamlined and user-friendly workflow, setting a new standard in cell sorting technology.

Caption: With FACSDiscover™ S8 Cell Sorters, significant advances in cellular analysis are now possible.

Innovation: The Bedrock of BD's New Cell Sorters

The call of innovation echoes loudly in the features of the new BD FACSDiscover™ S8 Cell Sorters, which incorporate breakthrough technologies such as BD CellView™ Image Technology and BD SpectralFX™ Technology. These technologies signal a vast improvement in real-time imaging and spectral flow cytometry, signifying a radical step in the evolution of BD's instruments. The newly unveiled three- and four-laser models build on the foundation set by the previously launched five-laser unit, offering scientists an array of options to enhance their research capabilities seamlessly.

"Based on my work in cellular biology, the configuration of the instrument was impeccable, especially in terms of the number of lasers and imaging facilities," remarked Dr. Daniel Schraivogel, a research staff scientist at EMBL. Schraivogel, an experienced user with approximately 600 hours on the three-laser prototype, praised the device's sorting speed and software, emphasizing the scalability and ease of use of the equipment.

The FACSDiscover™ S8 platform stands out not just for its speed and practicality, but also for its ability to revolutionize the quality and purity of sorted samples. With BD CellView™ Image Technology, scientists can be more confident in their biological findings, optimizing both time and resources for downstream applications. This technology is transformative, especially for drug discovery, immuno-oncology, and genomics research, accelerating the journey from experimental insights to practical cell-based treatments.

"In the arena of flow cytometry, suspect cell populations like dead or dying cells, doublets, and cellular debris can compromise the integrity of experiments," continued Schraivogel. "Beyond the invaluable spatial information crucial for many projects in cell biology, the imaging sorter's capability to accurately assess our cell populations validates single-cell gating and sorting, yielding superior cell quality and biological outcomes."

Witness the BD FACSDiscover™ Cell Sorters in Action

The family of BD FACSDiscover™ Cell Sorters will be showcased at multiple upcoming scientific conferences, starting with the American Association for Cancer Research (AACR) Annual Meeting, which takes place from April 5-10. Researchers interested in integrating these advanced sorting technologies into their work are encouraged to reach out to local sales representatives for further details. To discover more about these ground-breaking cell sorters, visit bdbiosciences.com/S8.

About BD - A Commitment to Advancing Global Health

BD stands tall as one of the world's most substantial global medical technology firms, committed to advancing the entire health spectrum. By fostering medical innovation, enhancing diagnostics, and improving the delivery of care, BD supports the heroes working tirelessly at the forefront of healthcare. With a workforce of over 70,000 dedicated individuals, BD's vision extends to making a significant impact on safety and efficiency in clinicians' care processes, from laboratories to patients. The company's global footprint spans nearly all countries, partnering with a vast network of entities to tackle some of the most pressing health challenges faced worldwide.

BD's continuous collaboration with customers is a testament to its mission—to bolster outcomes, reduce healthcare costs, augment efficiencies, and amplify patient safety and accessibility. Should you wish to learn more about BD's transformative work in the medical field, please visit bd.com, or connect with BD on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo, or Instagram @becton_dickinson.

Contact Information for Further Inquiries

For those seeking additional information or wishing to engage with BD on these revolutionary cell sorting technologies, detailed contact information is provided below:

Media Inquiries:

Troy Kirkpatrick
VP, Public Relations
Phone: 858.617.2361
Email: email protected

Investor Relations:

Adam Reiffe
Sr. Director, Investor Relations
Phone: 201.847.6927
Email: email protected

SOURCE BD (Becton, Dickinson and Company)

BD's commitment to fostering a healthier world and the recent introduction of the BD FACSDiscover™ S8 Cell Sorters reflect the company's deep-rooted dedication to driving forward medical research and patient care. With the launch of these advanced technologies, BD continues to set benchmarks in the medical technology industry, demonstrating that innovation is not just about creating new tools, but also about opening doors to new possibilities and enriching our understanding of life at the most fundamental level.

The image accompanying this announcement and deeper insights into the revolutionary capabilities of the BD FACSDiscover™ S8 Cell Sorters are available for viewing and sharing through the links provided above.

Note: Due to editorial guidelines and the evolving nature of technology, the content of the article may contain forward-looking statements based on current expectations and forecasts. For the most accurate and up-to-date information, please refer to official BD statements and resources.

(The content provided in the article is based solely on the information provided in the initial scraped news content and does not contain any additional observations or thoughts.)